Skip to Content

P 125 (Everolimus 5 mg)

Pill with imprint P 125 is White, Capsule-shape and has been identified as Everolimus 5 mg. It is supplied by Par Pharmaceutical, Inc..

Everolimus is used in the treatment of neuroendocrine carcinoma; breast cancer; pancreatic cancer; organ transplant, rejection prophylaxis; renal angiomyolipoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for P 125

Everolimus 5 mg P 125

Everolimus

Imprint
P 125
Strength
5 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
MTOR inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical, Inc.
National Drug Code (NDC)
49884-0125

Get help with Imprint Code FAQs.

Related Images for "P 125"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.